SENP2

SUMO1/sentrin/SMT3 specific peptidase 2
PDB rendering based on 1tgz.
Available structures PDB 1TGZ, 1TH0, 2IO0, 2IO1, 2IO2, 2IO3
Identifiers
Symbols	SENP2; AXAM2; DKFZp762A2316; KIAA1331; SMT3IP2
External IDs	OMIM: 608261 MGI: 1923076 HomoloGene: 11005 GeneCards: SENP2 Gene
Gene Ontology Molecular function • protein binding • peptidase activity • cysteine-type peptidase activity • SUMO-specific protease activity Cellular component • nucleus • nuclear pore • nucleolus • cytoplasm • membrane • PML body • nuclear membrane • intracellular membrane-bounded organelle Biological process • proteolysis • protein transport • protein desumoylation • regulation of Wnt receptor signaling pathway • mRNA transport • transmembrane transport Sources: Amigo / QuickGO
RNA expression pattern
More reference expression data
Orthologs
Species	Human	Mouse
Entrez	59343	75826
Ensembl	ENSG00000163904	ENSMUSG00000022855
UniProt	Q9HC62	Q91ZX6
RefSeq (mRNA)	NM_021627	NM_029457
RefSeq (protein)	NP_067640	NP_083733.1
Location (UCSC)	Chr 3: 185.3 – 185.35 Mb	Chr 16: 22.01 – 22.05 Mb
PubMed search	[1]	[2]

Sentrin-specific protease 2 is an enzyme that in humans is encoded by the SENP2 gene.

SUMO1 (UBL1; MIM 601912) is a small ubiquitin-like protein that can be covalently conjugated to other proteins. SENP2 is one of a group of enzymes that process newly synthesized SUMO1 into the conjugatable form and catalyze the deconjugation of SUMO1-containing species.[supplied by OMIM]

Interactions

SENP2 has been shown to interact with NUP153.

Further reading

• Mikolajczyk J, Drag M, Békés M, Cao JT, Ronai Z, Salvesen GS. (2007). "Small ubiquitin-related modifier (SUMO)-specific proteases: profiling the specificities and activities of human SENPs.". J. Biol. Chem. 282 (36): 26217–24. doi:10.1074/jbc.M702444200. PMID 17591783. 
• Drag M, Mikolajczyk J, Krishnakumar IM, Huang Z, Salvesen GS. (2008). "Activity profiling of human deSUMOylating enzymes (SENPs) with synthetic substrates suggests an unexpected specificity of two newly characterized members of the family.". Biochem J. 409 (2): 461–9. doi:10.1042/BJ20070940. PMID 17916063. 
• Nakajima D, Okazaki N, Yamakawa H, et al. (2003). "Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.". DNA Res. 9 (3): 99–106. doi:10.1093/dnares/9.3.99. PMID 12168954. 
• Nagase T, Kikuno R, Ishikawa KI, et al. (2000). "Prediction of the coding sequences of unidentified human genes. XVI. The complete sequences of 150 new cDNA clones from brain which code for large proteins in vitro.". DNA Res. 7 (1): 65–73. doi:10.1093/dnares/7.1.65. PMID 10718198. 
• Kadoya T, Yamamoto H, Suzuki T, et al. (2002). "Desumoylation activity of Axam, a novel Axin-binding protein, is involved in downregulation of beta-catenin.". Mol. Cell. Biol. 22 (11): 3803–19. doi:10.1128/MCB.22.11.3803-3819.2002. PMC 133821. PMID 11997515. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=133821. 
• Zhang H, Saitoh H, Matunis MJ (2002). "Enzymes of the SUMO modification pathway localize to filaments of the nuclear pore complex.". Mol. Cell. Biol. 22 (18): 6498–508. doi:10.1128/MCB.22.18.6498-6508.2002. PMC 135644. PMID 12192048. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=135644. 
• Best JL, Ganiatsas S, Agarwal S, et al. (2002). "SUMO-1 protease-1 regulates gene transcription through PML.". Mol. Cell 10 (4): 843–55. doi:10.1016/S1097-2765(02)00699-8. PMID 12419228. 
• Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=139241. 
• Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs.". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039. 
• Reverter D, Lima CD (2005). "A basis for SUMO protease specificity provided by analysis of human Senp2 and a Senp2-SUMO complex.". Structure 12 (8): 1519–31. doi:10.1016/j.str.2004.05.023. PMID 15296745. 
• Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=528928. 
• Itahana Y, Yeh ET, Zhang Y (2006). "Nucleocytoplasmic shuttling modulates activity and ubiquitination-dependent turnover of SUMO-specific protease 2.". Mol. Cell. Biol. 26 (12): 4675–89. doi:10.1128/MCB.01830-05. PMC 1489137. PMID 16738331. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1489137. 
• Reverter D, Lima CD (2007). "Structural basis for SENP2 protease interactions with SUMO precursors and conjugated substrates.". Nat. Struct. Mol. Biol. 13 (12): 1060–8. doi:10.1038/nsmb1168. PMID 17099700.